Iodide

Iodide

SCHEMBL2184645

CCCCC(=O)OC(C)C.I

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.80
MAPT P10636 4/20 0.52
MAPK1 P28482 2/20 0.52
ALDH1A1 P00352 2/20 0.48
PRKCA P17252 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCD Q05655 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
DGKA P23743 1/20 0.43
CYP1A2 P05177 2/20 0.42
TSHR P16473 1/20 0.41
MEN1 O00255 1/20 0.41
GMNN O75496 1/20 0.41
HSP90AA1 P07900 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NR1H4 Q96RI1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL127507 0.98 LMNA (0.83) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL5903196 0.95 LMNA (0.80) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL28462324 0.95 LMNA (0.80) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL121439 0.91 LMNA (0.96) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL126208 0.89 LMNA (1.00) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL1173030 0.89 LMNA (1.00) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL1278398 0.89 LMNA (1.00) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Palmitate SCHEMBL22578002 0.89 LMNA (1.00) LMNAMAPTMAPK1ALDH1A1PRKCA
SCHEMBL29523 0.89 LMNA (1.00) LMNAMAPTMAPK1ALDH1A1PRKCA
Isopropyl Palmitate SCHEMBL1133116 0.89 LMNA (1.00) LMNAMAPTMAPK1ALDH1A1PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011084850-A1 PRODRUGS FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISEASE ALKERMES, INC. (US) 2011-07-14 WO disclosed
US-20110166156-A1 Prodrugs for the Treatment of Schizophrenia and Bipolar Disease ALKERMES, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166156-A1 Prodrugs for the Treatment of Schizophrenia and Bipolar Disease SLC1A2, BDNF, MAOB LMNA 1728/4885MAPT 349/4885MAPK1 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.